Skip to main content

Clinical Trials Using Autologous Desmoglein-3 Chimeric Autoantibody Receptor T-cells DSG3-CAART

Review the clinical trials studying autologous desmoglein-3 chimeric autoantibody receptor t-cells dsg3-caart on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 1-1 of 1

A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)
Status: Active
Location: 2 locations